Trump Announces Deals to Lower Weight Loss Drug Prices and Expand Medicare Coverage
TL;DR Summary
President Trump announced agreements with Eli Lilly and Novo Nordisk to significantly reduce the prices of obesity drugs, expand Medicare coverage starting in 2026, and make these treatments more accessible and affordable for millions of Americans, including discounts for consumers and coverage for some Medicare beneficiaries.
- Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage CNBC
- Certain obesity drugs will cost as little as $149 and Medicare will start covering them under White House deals CNN
- Trump strikes deal to lower cost of Wegovy, Zepbound weight loss drugs NBC News
- Trump, long fixated on ‘fat drug,’ to announce deal to lower its price The Washington Post
- Trump says Medicare can now cover weight loss drugs like Ozempic Axios
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
6 min
vs 7 min read
Condensed
97%
1,338 → 46 words
Want the full story? Read the original article
Read on CNBC